Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer.
- DOI
- 10.1016/j.ejca.2024.114145
- Published
- 2024 Aug
- Container
- European journal of cancer (Oxford, England : 1990)
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ejca.2024.114145,
title = {Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer.},
author = {Pearson AD and DuBois SG and Macy ME and de Rojas T and Donoghue M and Weiner S and Knoderer H and Bernardi R and Buenger V and Canaud G and Cantley L and Chung J and Fox E and Friend J and Glade-Bender J and Gorbatchevsky I and Gore L and Gupta A and Hawkins DS and Juric D and Lang LA and Leach D and Liaw D and Lesa G and Ligas F and Lindberg G and Lindberg W and Ludwinski D and Marshall L and Mazar A and McDonough J and Nysom K and Ours C and Pappo A and Parsons DW and Rosenfeld A and Scobie N and Smith M and Taylor D and Weigel B and Weinstein A and Karres D and Vassal G},
year = {2024},
journal = {European journal of cancer (Oxford, England : 1990)},
doi = {10.1016/j.ejca.2024.114145},
url = {https://doi.org/10.1016/j.ejca.2024.114145}
}RIS
TY - JOUR TI - Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer. AU - Pearson AD AU - DuBois SG AU - Macy ME AU - de Rojas T AU - Donoghue M AU - Weiner S AU - Knoderer H AU - Bernardi R AU - Buenger V AU - Canaud G AU - Cantley L AU - Chung J AU - Fox E AU - Friend J AU - Glade-Bender J AU - Gorbatchevsky I AU - Gore L AU - Gupta A AU - Hawkins DS AU - Juric D AU - Lang LA AU - Leach D AU - Liaw D AU - Lesa G AU - Ligas F AU - Lindberg G AU - Lindberg W AU - Ludwinski D AU - Marshall L AU - Mazar A AU - McDonough J AU - Nysom K AU - Ours C AU - Pappo A AU - Parsons DW AU - Rosenfeld A AU - Scobie N AU - Smith M AU - Taylor D AU - Weigel B AU - Weinstein A AU - Karres D AU - Vassal G PY - 2024 JO - European journal of cancer (Oxford, England : 1990) DO - 10.1016/j.ejca.2024.114145 UR - https://doi.org/10.1016/j.ejca.2024.114145 ER -
APA
AD, P., SG, D., ME, M., T, D. R., M, D., S, W., H, K., R, B., V, B., G, C., L, C., J, C., E, F., J, F., J, G., I, G., L, G., A, G., DS, H., D, J., LA, L., D, L., D, L., G, L., F, L., G, L., W, L., D, L., L, M., A, M., J, M., K, N., C, O., A, P., DW, P., A, R., N, S., M, S., D, T., B, W., A, W., D, K., & G, V. (2024). Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer.. European journal of cancer (Oxford, England : 1990). https://doi.org/10.1016/j.ejca.2024.114145
Source records
- pubmed · retrieved 2026-09-26T08:51:19.242Z